Patents by Inventor Jonas Fagerhag

Jonas Fagerhag has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6750252
    Abstract: The present invention relates to certain tri-substituted phenyl derivatives and analogues of formula (I), to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: November 13, 2002
    Date of Patent: June 15, 2004
    Assignee: AstraZeneca AB
    Inventors: Maria Boije, Jonas Fägerhag, Eva-Lotte Lindstedt Alstermark, Bengt Ohlsson
  • Patent number: 6630509
    Abstract: The present invention relates to certain phenalkyloxy-phenyl derivatives of formula (I) and analogs, to a process for preparing such compounds, which compounds have utility in treating clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: June 3, 2002
    Date of Patent: October 7, 2003
    Assignee: AstraZeneca AB
    Inventors: Jonas Fägerhag, Lanna Li, Eva-Lotte Lindstedt Alstermark
  • Publication number: 20030149104
    Abstract: The present invention relates to certain tri-substituted phenyl derivatives and analogues of formula (I), to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: November 13, 2002
    Publication date: August 7, 2003
    Inventors: Maria Boije, Jonas Fagerhag, Eva-Lotte Lindstedt Alstermark, Bengt Ohlsson
  • Publication number: 20030018207
    Abstract: The present invention relates to certain phenalkyloxy-phenyl derivatives of formula (I) and analogs, to a process for preparing such compounds, having the utility in clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Application
    Filed: June 3, 2002
    Publication date: January 23, 2003
    Inventors: Jonas Fagerhag, Lanna Li, Eva-Lotte Linstedt Alstermark